U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06969755) titled 'Biomarkers to Enhance Early Schizophrenia Treatment' on April 04.
Brief Summary: This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Schizophenia Disorder
Intervention:
DRUG: aripiprazole
aripiprazole arm (titrated dose)
DRUG: risperidone
risperidone arm (titrated dose)
DRUG: clozapine
clozapine (titrated dose)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Northwell Health
Published...